Search Results - "Bove, Rachel"
-
1
Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas
Published in Nature (London) (13-11-2024)“…H3K27M-mutant diffuse midline gliomas (DMGs) express high levels of the disialoganglioside GD2 (ref. 1). Chimeric antigen receptor-modified T cells targeting…”
Get full text
Journal Article -
2
DIPG-47. SEQUENTIAL INTRAVENOUS AND INTRACEREBROVENTRICULAR GD2-CAR T-CELL THERAPY FOR H3K27M-MUTATED DIFFUSE MIDLINE GLIOMAS
Published in Neuro-oncology (Charlottesville, Va.) (18-06-2024)Get full text
Journal Article